Anesthetic and surgical management of tracheostomy in a patient with COVID-19.
Aged
Anesthesia, Local
/ methods
Betacoronavirus
COVID-19
Coronavirus Infections
/ surgery
Humans
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Lung
/ diagnostic imaging
Male
Neuromuscular Nondepolarizing Agents
/ administration & dosage
Pandemics
Personal Protective Equipment
Pneumonia, Viral
/ surgery
Radiography, Thoracic
Rocuronium
/ administration & dosage
SARS-CoV-2
Tomography, X-Ray Computed
Tracheostomy
/ methods
COVID-2019
SARS-COV-2
Surgical management
Tracheostomy
Journal
Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
02
04
2020
revised:
08
04
2020
accepted:
10
04
2020
pubmed:
30
4
2020
medline:
18
8
2020
entrez:
30
4
2020
Statut:
ppublish
Résumé
The ongoing pandemic coronavirus disease-2019 (COVID-19) infection causes severe respiratory dysfunction and has become an emergent issue for worldwide healthcare. Since COVID-19 spreads through contact and droplet infection routes, careful attention to infection control and surgical management is important to prevent cross-contamination of patients and medical staff. Tracheostomy is an effective method to treat severe respiratory dysfunction with prolonged respiratory management and should be performed as a high-risk procedure METHOD: The anesthetic and surgical considerations in this case involved difficult goals of the patient safety and the management of infection among health care workers. Our surgical procedure was developed based on the previous experiences of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). We described the management procedures for tracheostomy in a patient with COVID-19, including the anesthesia preparation, surgical procedures, required medical supplies (a N95 mask or powered air purifying respirator, goggles, face shield, cap, double gloves, and a water-resistant disposable gown), and appropriate consultation with an infection prevention team. Appropriate contact, airborne precautions, and sufficient use of muscle relaxants are essential for performing tracheostomy in a patient with COVID-19.
Identifiants
pubmed: 32345515
pii: S0385-8146(20)30082-1
doi: 10.1016/j.anl.2020.04.002
pmc: PMC7165273
pii:
doi:
Substances chimiques
Neuromuscular Nondepolarizing Agents
0
Rocuronium
WRE554RFEZ
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-476Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no financial conflicts of interest to declare.
Références
Emerg Infect Dis. 2004 Feb;10(2):251-5
pubmed: 15030692
Laryngoscope. 2003 Oct;113(10):1777-9
pubmed: 14520105
Br J Anaesth. 2004 Feb;92(2):280-2
pubmed: 14722185
Clin Chest Med. 2017 Mar;38(1):71-86
pubmed: 28159163
Respir Care. 2014 Jun;59(6):895-915; discussion 916-9
pubmed: 24891198
PLoS One. 2012;7(4):e35797
pubmed: 22563403
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Anesthesiology. 2004 Jun;100(6):1394-8
pubmed: 15166557
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Crit Care. 2015 Dec 04;19:424
pubmed: 26635016
Br J Anaesth. 2020 May;124(5):497-501
pubmed: 32115186
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264